Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
O., and Kremer, L
ShiraYuki is suitable for both men and women
Data extraction was conducted by two independent reviewers using a standardized form encompassing author details, publication year, study type, employed techniques, number of patients, patient demographics (age), follow-up duration, treatment efficacy outcomes (tumor volume decrease, local pain relief using Visual Analog Scale (VAS), and local pain-free survival, referring to the period during which the patient remains free from pain after the intervention), and AEs graded following the guidelines of the Society of Interventional Radiology (SIR) [13] and the National Cancer Institute Common Terminology Criteria Adverse Events (CTCAE, version 4.0)
This sequence conservation analysis revealed a substantial degree of variability in at least some of the candidates, suggesting that no single component would be sufficient to induce broad coverage and that a universal vaccine should contain multiple antigens (Figure 2)
US$ 21.16
US$ 21.69
US$ 21.78
US$ 29.24
US$ 21.53
US$ 27.10
US$ 24.58
US$ 22.94
US$ 25.50
US$ 29.40
US$ 20.86
US$ 25.95
